About the Journal

Cardiovascular Diagnostics and Biomarkers (CDB) will focus on the development of biomarkers and diagnostic strategies for cardiovascular diseases. It is intended to attract submissions involving omics-based profiling, point-of-care testing and diagnostic algorithm design. The journal will cater to translational and clinical research that strengthens early disease detection and refines risk stratification. Works of interest include biomarker-driven evaluation tools, diagnostic models and integrative methods combining molecular and imaging-based assessments.

Topics include but are not limited to:

• Discovery and evaluation of circulating biomarkers for cardiovascular diseases.
• Multi omics profiling for early detection, prognosis and disease stratification.
• Diagnostic classifiers and molecular signatures for ischemia, heart failure and arrhythmia.
• Point of care devices for rapid cardiac biomarker testing.
• Integration of molecular profiles into clinical diagnostic pathways and algorithms.
• Validation studies for emerging cardiovascular diagnostic assays.
• Biomarker driven precision medicine and personalised cardiology approaches.
• Translational research linking molecular findings to clinical decision making.